Xenon Pharmaceuticals XENE
NASDAQ XENE
$37.25 +0.53 (+1.44%)
At close: Sep 29, 2026 · 4:00 PM EDT

Xenon Pharmaceuticals (XENE) Share-based Compensation (IS) (2014 - 2015)

Updated

Xenon Pharmaceuticals (XENE) posted Share-based Compensation (IS) of -$1.88 million for Q2 2015, compared with $141,000 a year earlier.

Analysis

Xenon Pharmaceuticals (XENE) Share-based Compensation (IS) (2014 - 2015) Analysis & Trends

For the trailing twelve months through Jun 30, 2015, Share-based Compensation (IS) at Xenon Pharmaceuticals was $3.55 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn -
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn -
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Xenon Pharmaceuticals 3.55 Bn 3.55 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2015 -1.88 Mn
Mar 31, 2015 5.15 Mn
Jun 30, 2014 141,000.00
Mar 31, 2014 136,000.00
API Access

Xenon Pharmaceuticals Share-based Compensation (IS) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=XENE&period=max&api_key=YOUR_API_KEY